Mondo Visione Worldwide Financial Markets Intelligence

FTSE Mondo Visione Exchanges Index:

News Centre

  • TMX Group Remembers John Pearce Bunting, Former President And CEO Of Toronto Stock Exchange

    Date 02/05/2017

    TMX Group today offers sincere condolences on the passing of John Pearce Bunting.

  • The Shareholder Meeting Of Borsa Italiana Appointed The New Board Of Directors

    Date 02/05/2017

    The Shareholder Meeting of Borsa Italiana was held on 28 April.

  • Menivim Management Celebrates IPO In The Opening Bell Ceremony At TASE

    Date 02/05/2017

    The management of Menivim-The New REIT Ltd. took part in the Opening Bell Ceremony at the Tel Aviv Stock Exchange (TASE) on the occasion of the company's initial public offering. Menivim is the fifth new company to be joining the TASE this year; in fact, more companies have joined TASE in the first four months of 2017 than in all of last year.  Additionally, a number of companies are in the process of preparing IPOs, including another REIT company that will be joining TASE in the near future.  The overall value of REIT companies traded on the TASE totals approximately NIS 3.5 billion.

  • London Stock Exchange Group Plc - Total Voting Rights

    Date 02/05/2017

    The following notification is made in accordance with the FCA's Disclosure Guidance and Transparency Rules.

     

    As at close of business on 28 April 2017, London Stock Exchange Group plc has in issue 350,442,782 ordinary shares of 6 79/86 pence each.

     

    London Stock Exchange Group plc holds 1,099,040 of its ordinary shares in Treasury.

     

    Therefore, the total number of voting rights in London Stock Exchange Group plc is 349,343,742.

     

    The above figure 349,343,742 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, London Stock Exchange Group plc under the FCA's Disclosure Guidance and Transparency Rules.

     

  • Frost & Sullivan Publishes Initiation Coverage Report On Cellect Biotechnology - Equity Research Is Published In The framework Of The Tel Aviv Stock Exchange Analysis Program

    Date 02/05/2017

    Cellect Biotechnology Ltd, based in Israel, has developed an innovative technology  which enables the production of stem cells to therapies and treatments that require stem cells as the main ‘raw material’. The company trades on both the Tel Aviv Stock Exchange (TASE) and NASDAQ, and had a market capitalisation at TASE of ca. 45 million USD (prior to the release of Frost & Sullivan report on April 27th).